Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-004555
Filing Date
2020-02-13
Accepted
2020-02-13 20:57:11
Documents
2
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 5492
2 EX-24 DOCUMENT attachment1.htm EX-24 4368
  Complete submission text file 0000899243-20-004555.txt   11314
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address
Kumar Neil (Reporting) CIK: 0001742485 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38959 | Film No.: 20613198

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations